Citadel Advisors
ONEM

Citadel Advisors’s 1Life Healthcare ONEM Stock Holding History

Citadel Advisors’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,702,490
Closed -$28.4M – 16105
2022
Q4 		$28.4M Buy
1,702,490
+122,339
+8% +$2.07M 0.01% 1597
2022
Q3 		$27.1M Buy
1,580,151
+443,798
+39% +$6.97M 0.01% 1581
2022
Q2 		$8.91M Buy
1,136,353
+576,331
+103% +$4.95M ﹤0.01% 2849
2022
Q1 		$6.21M Buy
560,022
+157,386
+39% +$1.76M ﹤0.01% 3759
2021
Q4 		$7.07M Sell
402,636
-457,189
-53% -$8.87M ﹤0.01% 3697
2021
Q3 		$17.4M Buy
859,825
+618,240
+256% +$15.9M ﹤0.01% 2204
2021
Q2 		$7.99M Sell
241,585
-294,970
-55% -$11.1M ﹤0.01% 3486
2021
Q1 		$21M Sell
536,555
-187,252
-26% -$8.79M 0.01% 1902
2020
Q4 		$31.6M Buy
723,807
+552,383
+322% +$18.9M 0.01% 1352
2020
Q3 		$4.86M Sell
171,424
-15,693
-8% -$496K ﹤0.01% 3205
2020
Q2 		$6.8M Buy
187,117
+121,477
+185% +$3.42M ﹤0.01% 2668
2020
Q1 		$1.19M Buy
+65,640
New +$1.44M ﹤0.01% 5020

Citadel Advisors's ONEM Position: Q1 2023 in Review

Citadel Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,702,490 shares — an estimated $28.4M sold.

Citadel Advisors first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $31.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Citadel Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,702,490 1Life Healthcare shares in Q1 2023, an estimated $28.4M.
  • Citadel Advisors first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Citadel Advisors's 1Life Healthcare position peaked at $31.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.